Guido Antonelli to HIV-1
This is a "connection" page, showing publications Guido Antonelli has written about HIV-1.
Connection Strength
0.589
-
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome. Cytokine Growth Factor Rev. 2018 04; 40:19-31.
Score: 0.245
-
Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators. J Virol. 2019 11 01; 93(21).
Score: 0.068
-
Increased expression of IL-32 correlates with IFN-?, Th1 and Tc1 in virologically suppressed HIV-1-infected patients. Cytokine. 2019 08; 120:273-281.
Score: 0.066
-
Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation. J Immunol Res. 2018; 2018:1738676.
Score: 0.063
-
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis. 2017 08 22; 17(1):581.
Score: 0.059
-
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immun Inflamm Dis. 2017 09; 5(3):244-260.
Score: 0.057
-
Increased IL-17 and/or IFN-? producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women. AIDS. 2019 03 15; 33(4):627-636.
Score: 0.016
-
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors. J Glob Antimicrob Resist. 2017 09; 10:106-112.
Score: 0.015